pyridinolcarbamate has been researched along with Rhinitis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Rhinitis: Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Rodríguez, R | 1 |
| Rial, MJ | 1 |
| Esteban-Gorgojo, I | 1 |
| Veleiro Pérez, B | 1 |
| López-Araújo, GA | 1 |
| Pérez-Quintero, O | 1 |
| Carballas, C | 1 |
| Parra, A | 1 |
| Pineda, F | 1 |
1 other study available for pyridinolcarbamate and Rhinitis
| Article | Year |
|---|---|
Serodominance Profile in a Dust Mite Complex Region.
Topics: Allergens; Animals; Antigens, Dermatophagoides; Asthma; Dermatitis, Atopic; Female; Humans; Immunogl | 2022 |